In the year of TB, advocates want more than a political commitment
Development Financing, Drug Resistance, Innovation, Leadership, Medical DevicesJon RathauserTB, Tuberculosis, mHealth, Digital Health, WHO, Advocacy, diagnostics, Drug Compliance, Development Financing, Drug Resistance
Keheala Announces Investment by Check Point Software Technologies Co-Founder, Marius Nacht
Development Financing, Drug Resistance, Innovation, LeadershipJon RathauserMarius Nacht, Checkpoint, Investment, Development Financing, USAID, U.S. Agency for International Development, Unit 8200, Jon Rathauser, aMoon Fund, Behavioral Interventions, behavior change, disease, Infectious Disease, chronic disease, kenya, financing, innovation
Improved Diagnostics Fail to Halt the Rise of Tuberculosis
"Pandemic alert: Tuberculosis is world's No. 1 infectious killer" - CNBC
Development Financing, Drug Resistance, Leadership, Medical Devices, Lifestyle, Innovation, EvidenceJon Rathausertuberculosis, TB, Treatment, MDR TB, Drug Resistance, multidrug resistant TB, WHO, World Health Organization, Infectious Disease
The world is running out of antibiotics, WHO report confirms
Drug Resistance, LifestyleJon RathauserDrug Resistance, MDR TB, multidrug resistant TB, XDR TB, antibiotics, Medication, Medication Adherence, TB, Tuberculosis
Tuberculosis: Why the forgotten scourge remains a threat
TB Children Drug
